Pneumococcal Disease: Vaccination

Department of Health written question – answered on 16th December 2014.

Alert me about debates like this

Photo of Sir David Amess Sir David Amess Conservative, Southend West

To ask the Secretary of State for Health, with reference to the contribution by the Parliamentary Under-Secretary of State for Quality on 3 November 2014, House of Lords Official Report, column 1422, whether the recommendations made by the pneumococcal disease sub-committee of the Joint Committee on Vaccination and Immunisation (JCVI) will be adopted by the JCVI upon completion of the sub-committee's work.

Photo of Sir David Amess Sir David Amess Conservative, Southend West

To ask the Secretary of State for Health, with reference to the contribution by the Parliamentary Under-Secretary of State for Quality on 3 November 2014, House of Lords Official Report, column 1422, what the (a) membership and (b) terms of reference of the pneumococcal sub-committee of the Joint Committee on Vaccination and Immunisation will be.

Photo of Sir David Amess Sir David Amess Conservative, Southend West

To ask the Secretary of State for Health, with reference to the contribution by the Parliamentary Under-Secretary of State for Quality on 3 November 2014, House of Lords Official Report, column 1422, what opportunities there will be for external stakeholders to contribute to the Joint Committee on Vaccination and Immunisation's review of adult pneumococcal vaccination.

Photo of Jane Ellison Jane Ellison The Parliamentary Under-Secretary of State for Health

The advice of Joint Committee on Vaccination and Immunisation (JCVI) Sub-committees is considered by the JCVI, often alongside key evidence on which the advice is based. Following consideration of the evidence, the JCVI will make a decision on adoption of the Sub-committee’s advice.

The JCVI review of the adult pneumococcal vaccination programme will begin in spring 2015, with a review of the relevant evidence being undertaken by a JCVI Pneumococcal Sub-committee. As set out in the JCVI Code of Practice, the JCVI will consider the advice of the Sub-committee and may decide to issue an interim statement for a short period of consultation with those stakeholders who submitted evidence that informed the Committee’s advice.

The role of JCVI Sub-committees and the mechanism for selection of Sub-committee membership is described in the JCVI Code of Practice. The membership of established sub-committees is set out in minutes of the meetings and on the GOV.UK web site at:

https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation.

Draft terms of reference for the JCVI Pneumococcal Sub-committee will be considered and agreed at the first meeting of the sub-committee and recorded in the minute of the meeting.

The JCVI Code of Practice is available at:

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/224864/JCVI_Code_of_Practice_revision_2013_-_final.pdf

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.